6-anilino-5,8-quinolinedione has been researched along with Brain Neoplasms in 1 studies
6-anilino-5,8-quinolinedione: structure given in first source; SRS-A & guanylate cyclase antagonist
6-anilino-5,8-quinolinedione : A quinolone that is quinoline-5,8-dione in which the hydrogen at position 6 is replaced by an anilino group.
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of 6-anilino-5,8-quinolinedione (LY83583), an inhibitor of guanylyl cyclase (GC), on the growth of human brain tumor cells (U-373 MG astrocytoma and SK-N-MC neuroblastoma) was evaluated." | 3.69 | Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells. ( Lee, YS; Wurster, RD, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, YS | 1 |
| Wurster, RD | 1 |
1 other study available for 6-anilino-5,8-quinolinedione and Brain Neoplasms
| Article | Year |
|---|---|
Mechanism of potentiation of LY83583-induced growth inhibition by sodium nitroprusside in human brain tumor cells.
Topics: Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Astrocytoma; Brain Neoplasms; Calcium; | 1995 |